|
Video: What is a Stock Split?
|
|
Catalent is a holding company. Through its subsidiaries, Co. has two operating and reporting segments: Biologics and Pharma and Consumer Health. The Biologics segment provides development and manufacturing for biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells; and vaccines. The Pharma and Consumer Health segment comprises Co.'s capabilities for oral solids, softgel formulations, Zydis® fast-dissolve technologies, and gummy, soft chew, and lozenge dosage forms; formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms; and clinical trial development and supply services. According to our Catalent stock split history records, Catalent has had 0 splits. | |
|
Catalent (CTLT) has 0 splits in our Catalent stock split history database.
Looking at the Catalent stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Catalent shares, starting with a $10,000 purchase of CTLT, presented on a split-history-adjusted basis factoring in the complete Catalent stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/31/2014 |
|
End date: |
04/19/2024 |
|
Start price/share: |
$19.99 |
|
End price/share: |
$55.48 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
177.54% |
|
Average Annual Total Return: |
11.07% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$27,763.58 |
|
Years: |
9.73 |
|
|
|
|
|